Stay updated on Subcutaneous vs. Intravenous Daratumumab in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous vs. Intravenous Daratumumab in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous vs. Intravenous Daratumumab in Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The addition shows a new site revision label 'Revision: v3.3.3' and the deletions remove the 'HHS Vulnerability Disclosure' link along with the older 'Revision: v3.3.2' from the footer.
    Difference
    0.1%
    Check dated 2025-12-24T13:49:08.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows an added Revision: v3.3.2 and removes Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T11:53:33.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Removed the site-wide banner about government funding and operating status, which previously directed users to cc.nih.gov and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:21:56.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The new screenshot shows only updates to the record history page (added version entries and minor UI changes); there are no changes to the study data, status, or core details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T21:31:05.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    8%
    Check dated 2025-10-06T07:53:23.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software/version release with no evident changes to core content or functionality.
    Difference
    0.2%
    Check dated 2025-09-29T04:10:03.000Z thumbnail image

Stay in the know with updates to Subcutaneous vs. Intravenous Daratumumab in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs. Intravenous Daratumumab in Myeloma Clinical Trial page.